
Acute zzso zzso zzso zzso is the initial presentation in approximately zzso of cases of multiple sclerosis zzso and is characterized by zzso zzso painful visual loss without systemic or neurological zzso The zzso zzso Treatment Trial zzso has provided valuable insights into both the natural history and clinical course of zzso ON with respect to zzso Visual function improves spontaneously over weeks and within 12 months zzso have recovered to a visual acuity of at least zzso Treatment with high-dose zzso may accelerate visual recovery, but has little impact on long-term visual zzso In the zzso the 10-year risk of recurrence of zzso ON was zzso The presence of white matter zzso on the initial magnetic resonance image of the brain has been identified as the strongest predictor for the development of zzso The 15-year risk of developing zzso in the zzso was zzso with no zzso but zzso with one or more zzso Since there is evidence of early zzso damage in acute zzso zzso zzso drugs should be considered in patients at high risk of developing zzso in the future as prophylaxis against permanent neurological zzso 

